Investment Strategy Partners

ISP acted as the sole commercial advisor to banyan software on its acquisition of HMM – a leading B2B eHealth platform that helps health insurers, medical device suppliers, and healthcare providers manage the authorization, billing, and payment of medical aids

ISP acted as sole commercial advisor to VIA equity on its acquisition of TTools – a leading German provider of cloud-based practice management software for therapeutic practices

ISP acted as sole commercial advisor for an investment in VisionmaxX - a leading managed service provider (MSP) of IT services for medical practices across Germany

ISP acted as sole commercial advisor for an investment in SAPV CARE GmbH - a leading provider of specialized outpatient palliative care (SAPC) services in Germany

ISP acted as sole commercial advisor for an investment in VALEARA - a leading provider of ambulatory mental healthcare services in Germany

ISP acted as sole commercial advisor for an investment in AAC Praxisberatung - the leading software-based service provider for controlling and auditing of billing for physicians in Germany's statutory health insurance (GKV) system

ISP acted as the exclusive buy-side M&A advisor for the acquisition of DiaMed Beratungsgesellschaft für pharmazeutische Unternehmen – a well-established German Regulatory Affairs and Pharmacovigilance consultancy

ISP performed the Commercial VDD for the seller of Pentapharm AG – a leading supplier of biological agents for pharmaceutical and diagnostic applications with unique expertise in the field of haemostasis

ISP acted as sole commercial advisor for an investment in KLmed – a leading personnel service provider for medical healthcare facilities

ISP acted as sole commercial advisor for an investment in Bioarray – a leading Spanish diagnostic and research laboratory specializing in advanced genetic testing

ISP acted as sole commercial advisor for an investment in Paracelsus' rehab division – a leading German rehabilitation provider

ISP acted as the exclusive buy-side M&A advisor for the acquisition of S-cubed – a well-established UK-based Regulatory Affairs and Quality Assurance consultancy

ISP acted as exclusive buy-side M&A advisor for the acquisition of Quantify – a leading player in real-world evidence generation, health economics & outcomes research

ISP acted as exclusive buy-side M&A advisor for the acquisition of Biomapas – a leading player in pharmaceutical clinical research

ISP acted as sole commercial advisor for an investment in DMRZ – a leading cloud-based billing software for other healthcare providers

ISP acted as sole commercial advisor for the Vendor CDD Otto LSE – the leading EPC provider for GMP pharma production facilities in Central Europe

ISP acted as sole commercial advisor for an investment in A.R.C. Laser and Neolaser – two leading medical laser manufacturers

ISP acted as sole commercial advisor for an investment in VAMED – a major European stationary rehab provider

ISP acted as sole commercial advisor for an investment in Dermlite – the leading US Dermatoscope device manufacturer

ISP acted as sole commercial advisor for an investment in SDS – leading ceramic dental implant manufacturer

ISP acted as sole commercial advisor for an investment in Imes-icore – leading dental milling machine manufacturer

ISP acted as sole commercial advisor for the Vendor CDD Academia – leading DACH genetics/pathology laboratory platform

ISP acted as sole commercial advisor for an investment in CRS medical GmbH – a leading supplier of non-point-of care defibrillators

ISP acted as sole commercial advisor for an investment in MLase – the leading CDMO for medical excimer lasers

ISP acted as exclusive buy-side strategic transaction advisor for the Series B investment into Geneplanet – a preventive genetic testing player

ISP acted as sole commercial advisor for an investment in Sonnen Gesundheitszentrum – a leading laboratory for hemostaseology in Germany

ISP acted as sole commercial advisor for an investment in Genetikum – the leading laboratory for human genetics in Germany

ISP acted as strategic advisor to Laboratoire XO – a pharma co. focused on mature market authorizations, in their majority acquisition by Stanley Capital

ISP acted as sole commercial advisor for an investment in Heintel Medizintechnik – Austrians leading hospital focused MedTech distributor

ISP acted as sole commercial advisor for an anchor investment in Nexus – a leading hospital information system provider